Incassia 28 Day Shortage Update: What Patients Need to Know in 2026

If you've recently tried to refill your Incassia 28 Day prescription and hit a wall, you're looking for answers. Is there a shortage? Has something changed? Here is the most current information available on Incassia 28 Day availability in 2026.

Current Shortage Status: What the FDA Says

As of 2026, Incassia 28 Day (norethindrone tablets USP 0.35 mg) is not listed on the FDA's official drug shortage database. This means the FDA has not received or confirmed a formal shortage notification from the manufacturer, Aurobindo Pharma.

However, "not on the shortage list" does not mean universally available. Many patients continue to report difficulty finding Incassia at their local pharmacies, particularly in certain regions. Here's why that gap exists.

Why Patients Are Still Having Trouble Finding It

The FDA shortage list only captures medications where manufacturers have formally notified the agency of a shortage. Localized supply chain issues — delivery delays, distributor allocation gaps, high demand at specific pharmacies — often don't rise to the level of an official shortage but still affect real patients.

Contributing factors for Incassia specifically:

Single manufacturer. Incassia is produced by Aurobindo Pharma. If production slows for any reason — maintenance, raw material supply, quality review — distribution feels it quickly.

Many competing generics. Because norethindrone 0.35 mg comes in 10+ brand names, pharmacies may choose to stock only 1–2 of them. Incassia may simply not be the brand a given pharmacy ordered this month.

Post-2022 contraceptive demand shifts. Demand for progestin-only pills increased significantly in 2022–2023 following concerns about estrogen-based contraceptive access. Some of that increased demand has persisted, stressing generic supply chains.

Telehealth growth. Telehealth prescribing of norethindrone-based mini-pills surged after 2020. Increased prescriptions across the board have made stocking more unpredictable at retail pharmacies.

What This Means for Your Refill Timeline

Because every tablet in a norethindrone 28-day pack is active (there are no placebo pills), you cannot afford a gap between packs. Missing even a few doses significantly reduces the pill's effectiveness. Start looking for your next pack at least 10–14 days before your current pack runs out.

What Patients Can Do Right Now

Ask your pharmacist about other norethindrone 0.35 mg brands (Camila, Errin, Heather, Jencycla). These are FDA-equivalent generics and can typically be substituted without a new prescription.

Call multiple pharmacies. Availability varies widely from one location to the next. Don't assume your entire city is out.

Use medfinder — medfinder calls pharmacies near you to check which ones can fill your prescription. Results are texted to you.

Talk to your provider if norethindrone is consistently unavailable in your area. They may prescribe Slynd (drospirenone) or help you transition to a long-acting method.

Will the Situation Improve?

For medications like Incassia that are not in a formal FDA shortage, supply tends to self-correct relatively quickly. Manufacturers and distributors are incentivized to maintain supply for a drug with consistent high demand. Most patients who widen their search — either to other brands or other pharmacies — find their medication within a day or two.

The longer-term strategy is to get a 3-month supply whenever possible, use a mail-order pharmacy, and know which equivalent brands you can use as a backup. That way, a brief local stock gap never puts your contraceptive coverage at risk.

Related: Alternatives to Incassia 28 Day If You Can't Fill Your Prescription.